<b>Required disclosures for dietary supplements and medication; gluten disclaimer.</b> Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. The bill has a delayed effective date of July 1, 2027.
Raw source record
{
"id": 85485,
"url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb486\/",
"tags": {
"147959": "medicine",
"147960": "regulation",
"147961": "health",
"147962": "consumer protection",
"147963": "labeling"
},
"text": [
{
"date": "2026-01-13",
"number": "SB486",
"pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb486.pdf"
},
{
"date": "2026-02-05",
"number": "SB486S1"
}
],
"type": "bill",
"year": 2026,
"video": null,
"number": "sb486",
"patron": "Stuart, Richard",
"status": "failed committee",
"chamber": "senate",
"changes": null,
"outcome": "failed",
"related": [
{
"id": 84404,
"name": null,
"year": 2026,
"count": 3,
"number": "hb573",
"status": "signed by governor",
"catch_line": "Breast implants; Board of Medicine, et al., to create educational materials for patients.",
"date_introduced": "January 13, 2026"
},
{
"id": 85690,
"name": "Education and Health",
"year": 2026,
"count": 3,
"number": "sb641",
"status": "signed by governor",
"catch_line": "Office-based buprenorphine treatment; Board of Medicine to amend regulations.",
"date_introduced": "January 14, 2026"
},
{
"id": 84669,
"name": "Rules",
"year": 2026,
"count": 3,
"number": "hb831",
"status": "failed committee",
"catch_line": "Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.",
"date_introduced": "January 13, 2026"
},
{
"id": 83823,
"name": null,
"year": 2026,
"count": 3,
"number": "hb156",
"status": "signed by governor",
"catch_line": "Electronic Death Reg. System; requiring certain applicants for licensure to complete training.",
"date_introduced": "January 06, 2026"
},
{
"id": 84076,
"name": "Agriculture, Conservation and Natural Resources",
"year": 2026,
"count": 3,
"number": "sb186",
"status": "signed by governor",
"catch_line": "Misbranded food; manufactured-protein food products, civil penalty.",
"date_introduced": "January 09, 2026"
}
],
"summary": "<b>Required disclosures for dietary supplements and medication; gluten disclaimer.<\/b> Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. The bill has a delayed effective date of July 1, 2027.",
"version": "SB486S1",
"copatron": null,
"committee": null,
"full_text": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/3.2-5124.1\/'>3.2-5124.1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3319.1\/'>54.1-3319.1<\/a> as follows:<\/p>\n<p class=catchln><ins>\u00a7 3.2-<\/ins><ins>5<\/ins><ins>124.1. <\/ins><ins>Dietary<\/ins><ins> supplements; <\/ins><ins>ingredient disclosure; gluten disclaimer<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>For purposes of this section:<\/ins><\/p>\n<p class=section><ins>\"Active ingredient\" means any dietary ingredient intended to provide nutritional or physiological effect.<\/ins><\/p>\n<p class=section><ins>\"Dietary supplement\" means a product intended to supplement the diet that contains one or more dietary ingredients, including vitamins, herbs or other botanicals, amino acids, or other s<\/ins><ins>ubstances, and that is intended for ingestion in tablet, capsule, powder, or liquid form.<\/ins><\/p>\n<p class=section><ins>\"Inactive ingredient\" means any component of a dietary supplement other than an active ingredient, including excipients, fillers, binders, flavorings, colorings, preservatives, coatings, or processing aids.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>No person shall manufacture,<\/ins><ins> distribute, sell, or offer for sale in the Commonwealth a dietary supplement unless the product contains a clear, <\/ins><ins>legible, and conspicuous label <\/ins><ins>listing all active ingredients and inactive ingredients contained in the product.<\/ins><\/p>\n<p class=section><ins>C. No person shall manufacture<\/ins><ins>, distribute, sell, or offer for sale in the Commonwealth a dietary supplement that contains gluten unless the product contains a clear, legible, and conspicuous disclaimer separate from the list of active ingredients and inactive ingredients that states \"contains gluten.\"<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3319.1\/'>54.1-3319.1<\/a>. <\/ins><ins>Provision of <\/ins><ins>federally required <\/ins><ins>drug information.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>When dispensing a prescription drug to a patient, a pharmacist shall provide all <\/ins><ins>information required by federal law to accompany such drug, including the medication guide, patient package insert, <\/ins><ins>or<\/ins><ins> other written patient information.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>When dispensing a nonprescription drug directly to a patient, a pharmacist shall, upon request, <\/ins><ins>provide counseling consistent with <\/ins><ins>the labeling required under federal law.<\/ins><\/p>\n<p class=section><ins>C<\/ins><ins>. Nothing in this section shall be construed to require any labeling or disclosure for a drug that is different from or in addition to what is required under federal law.<\/ins><\/p>\n<p class=enactcls>2. That the provisions of the first enactment of this act shall become effective on July 1, 2027.<\/p>\n<p class=enactcls>3. That the Department of Agriculture and Consumer Services shall estimate the expected and potential costs associated with the implementation and administration of the provisions of the first enactment of this act. The Commissioner of Agriculture and Consumer Services shall submit a report on (i) such cost estimates, (ii) any legislative or regulatory recommendations related to the implementation and administration of the first enactment of this act, and (iii) any other recommendations related to the implementation and administration of the first enactment of this act to the Governor and the General Assembly no later than November 1, 2026.<\/p>",
"catch_line": "Gluten disclaimer; required disclosures for dietary supplements and medication.",
"duplicates": null,
"session_id": 32,
"word_count": 572,
"patron_party": "R",
"patron_place": "Montross",
"summary_hash": "9fced43bb1d211d625b568a87aa9bd13",
"patron_prefix": "Sen.",
"patron_suffix": "(R-Montross)",
"status_detail": "failed committee",
"_rsun_versions": [
{
"id": "1554ab06886ea5db1af74e051ed2b88a8ecdf240be0d2ae014bd3b1d858132a1",
"code": "SB486S1",
"bill_id": 85485,
"source_url": null,
"source_date": "2026-02-05",
"source_hash": "e706725b8718318b74121d50314058a261d5eb982e6882fb0ae7c941c8a0302f",
"source_html": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/3.2-5124.1\/'>3.2-5124.1<\/a> and <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3319.1\/'>54.1-3319.1<\/a> as follows:<\/p>\n<p class=catchln><ins>\u00a7 3.2-<\/ins><ins>5<\/ins><ins>124.1. <\/ins><ins>Dietary<\/ins><ins> supplements; <\/ins><ins>ingredient disclosure; gluten disclaimer<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>For purposes of this section:<\/ins><\/p>\n<p class=section><ins>\"Active ingredient\" means any dietary ingredient intended to provide nutritional or physiological effect.<\/ins><\/p>\n<p class=section><ins>\"Dietary supplement\" means a product intended to supplement the diet that contains one or more dietary ingredients, including vitamins, herbs or other botanicals, amino acids, or other s<\/ins><ins>ubstances, and that is intended for ingestion in tablet, capsule, powder, or liquid form.<\/ins><\/p>\n<p class=section><ins>\"Inactive ingredient\" means any component of a dietary supplement other than an active ingredient, including excipients, fillers, binders, flavorings, colorings, preservatives, coatings, or processing aids.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>No person shall manufacture,<\/ins><ins> distribute, sell, or offer for sale in the Commonwealth a dietary supplement unless the product contains a clear, <\/ins><ins>legible, and conspicuous label <\/ins><ins>listing all active ingredients and inactive ingredients contained in the product.<\/ins><\/p>\n<p class=section><ins>C. No person shall manufacture<\/ins><ins>, distribute, sell, or offer for sale in the Commonwealth a dietary supplement that contains gluten unless the product contains a clear, legible, and conspicuous disclaimer separate from the list of active ingredients and inactive ingredients that states \"contains gluten.\"<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/54.1-3319.1\/'>54.1-3319.1<\/a>. <\/ins><ins>Provision of <\/ins><ins>federally required <\/ins><ins>drug information.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>When dispensing a prescription drug to a patient, a pharmacist shall provide all <\/ins><ins>information required by federal law to accompany such drug, including the medication guide, patient package insert, <\/ins><ins>or<\/ins><ins> other written patient information.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>When dispensing a nonprescription drug directly to a patient, a pharmacist shall, upon request, <\/ins><ins>provide counseling consistent with <\/ins><ins>the labeling required under federal law.<\/ins><\/p>\n<p class=section><ins>C<\/ins><ins>. Nothing in this section shall be construed to require any labeling or disclosure for a drug that is different from or in addition to what is required under federal law.<\/ins><\/p>\n<p class=enactcls>2. That the provisions of the first enactment of this act shall become effective on July 1, 2027.<\/p>\n<p class=enactcls>3. That the Department of Agriculture and Consumer Services shall estimate the expected and potential costs associated with the implementation and administration of the provisions of the first enactment of this act. The Commissioner of Agriculture and Consumer Services shall submit a report on (i) such cost estimates, (ii) any legislative or regulatory recommendations related to the implementation and administration of the first enactment of this act, and (iii) any other recommendations related to the implementation and administration of the first enactment of this act to the Governor and the General Assembly no later than November 1, 2026.<\/p>",
"source_metadata": {
"bodyAssociation": "archive-reported-current-version",
"archiveReference": {
"date": "2026-02-05",
"number": "SB486S1"
}
}
}
],
"copatron_count": 0,
"patron_address": [
"P.O. Box 1146",
"Montross",
"VA 22520"
],
"patron_chamber": "senate",
"patron_started": 2008,
"session_lis_id": 261,
"status_history": [
{
"date": "03\/10\/2026",
"status": "Left in Health and Human Services",
"date_raw": "2026-03-10",
"vote_count": null,
"lis_vote_id": null,
"translation": "failed committee"
},
{
"date": "02\/26\/2026",
"status": "Subcommittee recommends continuing to 2027 (Voice Vote)",
"date_raw": "2026-02-26",
"vote_count": null,
"lis_vote_id": "299094",
"translation": "failed subcommittee"
},
{
"date": "02\/23\/2026",
"status": "Assigned sub: Social Services",
"date_raw": "2026-02-23",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "02\/16\/2026",
"status": "Assigned sub: Health",
"date_raw": "2026-02-16",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "02\/12\/2026",
"status": "Referred to Committee on Health and Human Services",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "02\/12\/2026",
"status": "Read first time",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/12\/2026",
"status": "Placed on Calendar",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/09\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB486)",
"date_raw": "2026-02-09",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/09\/2026",
"status": "Read third time and passed Senate Block Vote (40-Y 0-N 0-A)",
"date_raw": "2026-02-09",
"vote_count": null,
"lis_vote_id": "295425",
"translation": "passed senate"
},
{
"date": "02\/06\/2026",
"status": "Engrossed by Senate - committee substitute Block Vote (Voice Vote)",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/06\/2026",
"status": "Finance and Appropriations Substitute agreed to",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/06\/2026",
"status": "Engrossed by Senate Block Vote (Voice Vote)",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": "295193",
"translation": null
},
{
"date": "02\/06\/2026",
"status": "Read second time",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Passed by for the day",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Passed by for the day Block Vote (Voice Vote)",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": "294854",
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": "294853",
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Rules suspended",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Committee substitute printed 26107162D-S1",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/04\/2026",
"status": "Senate committee offered",
"date_raw": "2026-02-04",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/04\/2026",
"status": "Reported from Finance and Appropriations with substitute (15-Y 0-N)",
"date_raw": "2026-02-04",
"vote_count": null,
"lis_vote_id": "294390",
"translation": "passed committee"
},
{
"date": "02\/04\/2026",
"status": "Reported from Finance and Appropriations with substitute",
"date_raw": "2026-02-04",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed committee"
},
{
"date": "01\/30\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB486)",
"date_raw": "2026-01-30",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "01\/29\/2026",
"status": "Reported from Education and Health and rereferred to Finance and Appropriations (15-Y 0-N)",
"date_raw": "2026-01-29",
"vote_count": null,
"lis_vote_id": "293024",
"translation": "passed committee"
},
{
"date": "01\/29\/2026",
"status": "Reported from Education and Health and rereferred to Finance and Appropriations",
"date_raw": "2026-01-29",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed committee"
},
{
"date": "01\/27\/2026",
"status": "Assigned Education sub: Health",
"date_raw": "2026-01-27",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "01\/13\/2026",
"status": "Referred to Committee on Education and Health",
"date_raw": "2026-01-13",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "01\/13\/2026",
"status": "Prefiled and ordered printed; Offered 01-14-2026 26105005D",
"date_raw": "2026-01-13",
"vote_count": null,
"lis_vote_id": null,
"translation": "introduced"
}
],
"chief_patron_id": 309,
"date_introduced": "2026-01-13",
"patron_district": 25,
"patron_shortname": "rhstuart",
"committee_chamber": null,
"status_detail_date": "03\/10\/2026",
"committee_shortname": null,
"patron_name_formatted": "Sen. Richard Stuart (R-Westmoreland)"
}